AI-generated summary
The authors used isolated rat bronchi, some exposed to an inflammatory stimulus, to test whether 655 nm low level laser therapy could reduce smooth muscle dysfunction. They report that the laser partially reduced hyperreactivity, restored relaxation and lowered TNF-alpha mRNA expression, and that an NF-kappaB antagonist blocked this effect. The study was ex vivo, so findings do not directly indicate effects in living patients.
- Who or what was studied
- Bronchi segments dissected from Wistar rats, with and without inflammatory induction
- Wavelengths
- 655 nm
- Limits stated in the abstract
- The study was an ex vivo rat tissue experiment, so results may not apply to living humans.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 655 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Inflammation, Laser, Wavelength, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.